13 Things I Got Rid Of After Deciding I'm Done Having Kids
I'm the lucky mama to two smart, silly, special, and sweet little girls. My daughters are aged 2 and 4, and I feel grateful and lucky to be their parent. I also feel complete. For a host of personal reasons, my husband and I decided we are done having kids — and with that comes a whole lot of stuff to throw away.
Between trying to get pregnant, actually becoming so, and taking care of newborns, I've amassed so much stuff. For a time, I held onto much of it under the guise of 'what if.' What if we decide to try for a third, what if I get pregnant unintentionally, what if I meet another mom who could use any of it. All those 'what ifs' have left my bathroom, closet, and dresser overflowing.
There's also the emotional weight, as getting rid of these things signals an end to one of the most meaningful and yearned-for periods of my life. The simple act of decluttering can feel sad and difficult. However, it also can be positive. Clinging to unused ovulation sticks and nursing ointments doesn't allow me to focus on the present, or the future. And so, if you're at a similar crossroads, I invite you to join me and discard the things that are piling up, and make space for the next great chapter to come.
Anyone who is trying specifically to have kids will likely lean on an ovulation tracker of some kind to up their chances of conceiving. I used ovulation sticks for all of my pregnancies, and bought more than I ended up needing. A pile of unused ones is still sitting in my bathroom and because they're linked to a specific tracker, I couldn't even donate them if I wanted to. I'll never need these again, so they can go into the trash.
In addition to ovulation trackers, I bought a bunch of pregnancy tests to use every month when trying to conceive. Even after having my first child, I never tossed them out, as I knew the day would come when we would try to have a second. Now that we're done, these only add unnecessary clutter — especially because they're expired and I can't give them away to fellow mamas-to-be (although I wish I could, as they're not exactly cheap).
I suffered with a lot of nausea in my pregnancies and required over-the-counter help. I also needed additional medications while pregnant due to my 'advanced maternal age,' which I was so lovingly reminded of at every OB-GYN appointment. All of those pills and tablets are still in my medicine cabinet, and while I'm guilty of holding on to other regular, everyday medicines for far too long, I can't foresee any situation where I'd need these specific-use medications again.
I could use a good clothing declutter session in general to rid myself of old 'going out tops' or formerly trendy pieces that now induce a good deal of cringe. But even more unnecessary are my maternity clothes. There's no scenario where I will wear full-belly-coverage leggings, hidden panel nursing tops, or under-belly drawstring linen pants.
In adolescence I was prone to stretch marks, so in pregnancy I religiously slathered on creams and oils that promised to prevent them. And while their hydration qualities in general are nice, they're a bit heavy for everyday use and no longer what I reach for when my skin needs a drink — even on super-dry days. Out they go.
The so-called fourth trimester isn't spoken about enough. In my opinion, it's harder than pregnancy itself — and that's coming from someone who spent much of her pregnancy colored green or awake at all hours with insomnia. After giving birth, in addition to caring for an infant and navigating a flood of hormonal changes, a new mom must also recover from the trauma of childbirth. My deliveries were very different, but in both instances I needed things like peri bottles, sitz baths, postpartum ice packs, special underwear, and cooling foams and pads — all of which I've yet to throw away.
When it comes to feeding babies, however you do it, fed is best. I personally nursed my babies and struggled a lot in the beginning. Eventually, we got into a good rhythm but only after relying on aids such as nipple shields, lanolin creams, and cooling gel pads to help my baby latch and relive my discomfort. And would you believe it? All of those items are still in my house and ready to make their way out.
Similar to above, I only wore nursing bras for years. Because they're convenient and more comfortable than regular bras, I kept wearing them after weaning, too. But I've now realized these bras no longer serve or support my changed body. While I haven't missed underwire over the past few years, I know I'm ready to go back to regular bras.
Babies grow so quickly, and the adorable onesies you so excitedly picked out, in reality, may only get two or three wears. Couple that with the fact that friends and family love to give clothes to new babies, and you'll quickly end up with more clothes than you know what to do with. For a while, I held onto clothes for sentimental value, or to give to friends. But with bins overflowing, it's time to bring them all to the nearest donation center.
When I was pregnant for the first time, every list of must-have baby items I read included receiving blankets. So I stocked up on a bunch, and was gifted even more. Do you know what we never used at all? Receiving blankets. I still have no fewer than 20. I previously tried to organize them, and while that helped, most of these need to go (aside from one of two that I'll hold onto for sentimental sake).
While I'm not quite done changing diapers just yet, there are other things I no longer need that my kids used as infants. For example: baby nasal aspirators for tiny stuffy noses, gripe water for upset tummies, gas and colic relief products, and teething rings and toys.
Even though my girls were primarily breastfed, they took bottles from time to time as babies. I purchased so many kinds in the early days to see what they'd like. Now my daughters have graduated to sippy cups and straw Thermoses, and yet I still have a cabinet full of old bottles. Some are intact but too dusty to give away, while others are missing parts entirely.
There are plenty of big items we still use, like a crib or a kids' dresser. But our bassinet stroller attachment? No longer needed. Baby bouncer? Bye bye. A baby walker? We're done with that. Same for baby carriers, infant loungers, sit-to-stand activity centers, rattles, and tummy-time mats. And in the case of my 4-year-old, much of her aged-out stuff can't be reused by my 2-year-old who already has her own duplicate. This includes a diaper pail and caddy, changing table top, and a rocking chair. Removing these large items will make the biggest difference to clear space in a home.
Home: Where Your Story Starts
How a Cheerful DIY 'Drop Zone' Made This Whole Space Work Smarter
3 DIY Paint Projects with Pro Results
Sign up for Apartment Therapy's Daily email newsletter to receive our favorite posts, tours, products, and shopping guides in your inbox.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Is it a Great Time to Invest in Danaher Corp. (DHR)?
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 Value Index, which returned 3.79% for the same period. The fund's top 5 holdings are also listed in the letter, showing the firm's main investment positions heading into 2025. One of the companies mentioned in the letter is Danaher Corporation (NYSE:DHR). Danaher Corporation (NYSE:DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. Over the past month, Danaher Corporation (NYSE:DHR) rose by 7.69%, and its shares lost -23.01% of their value over the last 12 months. On August 12, 2025, Danaher Corporation (NYSE:DHR) shares closed at $205.72, with a market capitalization of $147.3 billion. Here is what they have to say about Danaher Corporation (NYSE:DHR) in their investor letter: "Danaher Corporation's (NYSE:DHR) valuation is attractive, considering its scale advantages and deeply embedded products in biopharma workflows, which are difficult to replace without regulatory reapproval. Additionally, the company's market dominance positions it well to benefit from secular growth trends in biologics, genetic medicine and diagnostics. Although the industry faces near-term demand, policy and tariff challenges, we believe these factors have been largely reflected in the valuation." A healthcare professional in a lab coat holding a microscope and looking at a slide under the Danaher Corporation (NYSE:DHR) ranks 27th in our list of the 30 most popular stocks among hedge funds. According to our data, 117 hedge fund portfolios held positions in Danaher Corporation (NYSE:DHR) at the end of the first quarter of 2025, up from 101 in the previous quarter. DHR was able to beat earnings expectations as it reported an EPS of $1.8, beating expectations of $1.64. While we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Danaher Corporation (NYSE:DHR) and Jim Cramer's views on the company. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares
We recently published Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing stocks on Tuesday. Shares of telehealth company Hims & Hers Health dropped by 4.04 percent on Tuesday as investors mirrored a selloff from key executives of the company, which included none other than its CEO. In a regulatory filing, Hims & Hers Health, Inc. (NYSE:HIMS) said its CEO, Andrew Dudum, sold $33.4 million of shares in the company, involving 660,000 units at a price of $50.58 apiece. The transaction was aimed at cashing in on gains from the stock's recent rally. Despite the sale, Dudum remains the largest individual shareholder, owning 8 million indirect shares and 92,313 direct holdings in Hims & Hers Health, Inc. (NYSE:HIMS). Meanwhile, other key executives also resorted to profit-taking in the past trading days. In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while Chief Medical Officer Patrick Carroll disposed of 60,000 shares for a total of $3.2 million. Copyright: wasansos1 / 123RF Stock Photo Since the start of the month, shares of Hims & Hers Health, Inc. (NYSE:HIMS) have already dropped by 27.5 percent. While we acknowledge the potential of HIMS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Cardinal Health (CAH) Falls on Dismal Revenue Performance
We recently published Cardinal Health, Inc. (NYSE:CAH) is one of the worst-performing stocks on Tuesday. Cardinal Health dropped its share prices by 7.21 percent on Tuesday to finish at $146.3 apiece as investors soured on its dismal revenue performance in both the fourth quarter and the full fiscal period of 2025. In its updated report, Cardinal Health, Inc. (NYSE:CAH) said revenues in the fourth quarter of the year finished flat at $60 billion, but attributable net income grew by 11 percent to $501 million from $450 million in the same period last year. In the full fiscal year of 2025, revenues decreased by 2 percent to $222.6 billion from $226.8 billion last year. Attributable net income, however, grew by 7 percent to $2 billion from $1.9 billion year-on-year. In other news, Cardinal Health, Inc. (NYSE:CAH) announced the acquisition of Solaris Health through its management services organization (MSO), The Specialty Alliance. A dose bottle of the medication is in the medical tech's hand Under the transaction, Cardinal Health, Inc. (NYSE:CAH) will infuse $1.9 billion in cash into The Specialty Alliance, in turn, raising its ownership in the latter to approximately 75 percent. Cardinal Health said it expects the transaction to close by the end of the year, subject to closing conditions, including the receipt of required physician and regulatory approvals. While we acknowledge the potential of CAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .